Fauci said babies and toddlers could be eligible for a COVID-19 vaccine by early 2022

Director of the National Institute for Allergies and Infectious Diseases Anthony FauciAnthony FauciGOP Senate Candidate Says Fauci is a “mass murderer” and should be jailed rather than a “hero”. said Thursday that babies and toddlers aged 6 months to 5 years old, although he “can’t guarantee that,” could be eligible for COVID-19 vaccination by spring.

“Hopefully it will be available to them in a reasonably short period of time, likely early next year in 2022, in the first quarter of 2022,” Fauci told Insider in an interview, but cautioned he was speculating, adding, “You need to conduct a clinical study. ”

Pfizer-BioNTech had previously announced that the results of its clinical study in children aged 2 to 5 years and 6 months to 2 years are expected as early as the fourth quarter of this year.

Pfizer expects to file for approval of its COVID-19 vaccine for children ages 6 months to 5 years old this month, the latter of which is not yet vaccinated in the U.S., according to a report by ABC Tampa in late October.

“The Food and Drug Administration and CDC will not approve the vaccine until some safety and efficacy data are available,” Philip Landrigan, a pediatrician and immunologist at Boston College, told CNN Health earlier this month.

“There is every reason to believe that it will be safe and effective,” added Landrigan. “But the authorities rightly need to be careful and will not give permission until they have the data.”

According to CNN, Pfizer is most advanced in studies for people ages 6 months to 5 years old, but Moderna also conducts studies in very young children.

“We don’t have enough data now to come up with a regulatory approach, but right now the data is being collected and analyzed,” Fauci told CNN earlier this month. “So we will be able to answer the question about safety and immunogenicity in people under the age of 5, I believe, within a reasonable time.”

According to CNN, Johnson & Johnson is currently in the first phase 3 study in adolescents aged 12 to 17 years and expects results in the coming months.

The White House announced on Wednesday that 10 percent of children ages 5 to 11 had received their first coronavirus vaccination after Pfizer’s pediatric dose was approved.

Leave a Comment